Introduction: Annually, >50% of the US population reports musculoskeletal (MSK) pain to a provider, with direct health care costs exceeding $185 billion. The number of MSK complaints and the associated costs are projected to rise, increasing demand for and burden on providers. Establishing new care models to decrease inefficiencies may ease this burden, lower costs, and optimize care delivery. The purpose of the Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home (IMPaC) study is to compare initial evaluation by a physical therapist (PT) integrated into primary care versus initial evaluation by a primary care provider (PCP) for patients with an MSK complaint.
billion. [1] In addition, opioid prescriptions for MSK pain have increased 142% from 2009-2011, [1] and there are 2.6 million annual emergency department (ED) visits for back pain alone. [2] Patients with MSK complaints commonly enter the health care system through primary care. Nearly 31% of people with MSK conditions have at least 1 visit with a primary care provider (PCP) yearly, with an overall average of 6 visits a year. [3] However, clinical guidelines recommend physical therapy as front-line care for MSK conditions. Recent studies have demonstrated that early referral to a physical therapist for low back pain can decrease health care costs by reducing imaging, specialist referrals, and opioid prescriptions. [4] [5] [6] Nevertheless, physical therapy referrals for MSK pain evaluation and management are disproportionate to the need, [7] and the uptake of clinical guidelines has been slow. [8] [9] [10] To make matters worse, referral for physical therapy at an offsite location (which is standard practice) may negatively impact care continuity, provider communication, collaboration, and patient satisfaction. In contrast, coordinated care models (i.e., co-location and integration) have been shown to positively impact outcomes for prevalent conditions in primary care, but data on the effectiveness of these models for MSK conditions are lacking.
Co-location has proven successful for primary care and mental-health services, nearly doubling the rate of guidelinebased care [11] and facilitating collaboration and referral due to proximity of specialized services. [12] We have shown that co-location of physical therapy services within primary care can help decrease opioid prescriptions and ED visits. [13] On the other hand, integration of services is less common and more challenging. It requires a dedicated team of providers with unified care plans and implies organizational and cultural collaboration. To our knowledge, it is unknown whether integrating physical therapy services within primary care for MSK complaints can decrease costs and utilization of US health care services. Therefore, the purpose of the Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home (IMPaC) study is to examine the effects of initial evaluation by an integrated physical therapist within primary care compared with usual PCP management for patients with an MSK complaint entering a primary care setting. 
METHODS AND ANALYSIS
We followed the Standard Protocol Items: Recommendations for Interventional Trials (SPiRIT) checklist, composed of 33 items focused on the content of reporting protocols for clinical trials. [14] 
Study design
IMPaC is a single site, randomized clinical trial of a novel health system redesign to study the effect of an initial evaluation by a physical therapist integrated into primary care versus PCP standard evaluation for MSK conditions within the primary care setting at a large academic medical center.
Participant eligibility and recruitment
All existing patients (n=3918), defined as establishing care within the past 3 years and having at least 1 visit in the last 12 months, at the Duke Outpatient Clinic will be mailed an announcement (opt-in/opt-out) letter about the study. Existing patients, all of whom should have received an announcement letter, will be recruited in 3 ways: 1) patients who contact the research coordinator for eligibility screening; 2) patients who contact the main scheduling center for an MSK complaint; and 3) patients who are on the daily schedule with an MSK complaint. All patients not meeting the definition of a current patient will be considered a new patient. Patients establishing care at the site for the first time will be recruited by either responding to an announcement letter or via referral by their new provider to the study research coordinator.
Enrollment and overview
Participants who call the scheduling center or contact the research coordinator about the study will be screened for eligibility and asked to verbally consent to participate. Following verbal consent by the research coordinator, participants will be randomized to an intervention arm by use of a computer-generated randomization table programmed into the study tracking database. Due to the nature of the intervention, both patients and interventionists will not be blinded to group assignment. Upon initial visit to the clinic, participants will provide written consent, demographic information, and health status. Patients assigned to the physical therapist group will receive an evaluation for their MSK complaint(s) by a licensed physical therapist onsite and will be provided with a treatment plan that will follow usual care currently implemented in clinical practice. Patients may return to the Duke Outpatient Clinic for followup treatments if the physical therapist deems it medically necessary or may be referred for physical therapy offsite.
Patients assigned to the PCP group will receive an initial evaluation from a licensed primary care provider onsite that will follow usual care. The PCP may then refer the patient for physical therapy. If so, the patient will be randomly assigned to either the physical therapist onsite or referral to an offsite physical therapy clinic of the patient's choosing, with the assistance of the research coordinator. If the PCP decides that physical therapy is not medically necessary, the patient will follow the PCP's usual plan of care and treatment recommendations. Following evaluation by either the physical therapist or PCP, the research coordinator will ask the patient to complete a short patient satisfaction survey about the initial visit. Participants will receive a gift worth $20 for completing the baseline requirements. After approximately 3 months, the research coordinator will contact all enrolled patients by phone to collect health statuses and satisfaction measures. Also, at 3 months, outcomes related to total and MSK costs/charges will be collected via the Duke University Health System Department of Finance, opioid prescriptions and ED visits will be collected via electronic health records and administrative data, and offsite referrals to physical therapy will be collected via administrative data from the Department of Physical and Occupational Therapy. Investigators will also collect, via electronic health record, usual care measures of functional status. The study will end following the 3-month follow-up phone call and collection of outcomes and data.
Inclusion/exclusion criteria
Potential participants will be considered eligible if they have an MSK pain complaint and are within the target sample population. Based on clinical experience at the research site, any adult (≥18 years) reporting an MSK pain complaint will be included. Patients without legal capacity (mental or psychological stability) to provide informed consent will be excluded. Patients will be withdrawn from the study if the physical therapist believes the patient may have an underlying medical condition that makes the patient inappropriate for physical therapy care. [15, 16] In this case, the participant will be referred to a clinic PCP for further evaluation. 
Study interventions
All aspects of the physical therapy care provided for MSK complaints will be based on usual care. (Current practice at the study clinic consists of an onsite physical therapist to provide PCP referral-based examinations, onsite and home-based exercise programs, and pain-control education.) Our study will consist of 2 interventions: 1) physical therapist evaluation first, or 2) PCP evaluation first with possible physical therapy referral.
Physical Therapist Evaluation: This intervention builds upon our current clinical model of a physical therapist colocated within the Duke Outpatient Clinic. The physical therapist has an assigned treatment room, is available for scheduled follow-up appointments, attends staff meetings and events, and is considered a provider within the Duke Outpatient Clinic system. Co-location is fully supported by the administration of the clinic and the Department of Physical Therapy and Occupational Therapy. The utilization of physical therapy services is considered usual care; however, the timing of services is unique given the co-location. This allows for prompt access to not only a physical therapy evaluation (billing for services occurs), but for consultation with a PCP (a contact note for consultation is included in the patient's medical records). For IMPaC, investigators will utilize this co-located physical therapist as a front-line provider for patients seeking care for MSK complaints at the clinic. The physical therapy evaluation will be usual care and will not be modified in any way for the purposes of the study. If, at any time during evaluation, the physical therapist determines that the patient would benefit from an additional PCP assessment, the patient will be scheduled for one. These referrals from the physical therapist to the PCP can occur within the same day, which adds considerable efficiency.
PCP Evaluation: In this cohort, patients will undergo initial assessment by the PCP, which is considered usual care. If the PCP deems that the patient should be referred for physical therapy for medically necessary treatment, the research coordinator will randomly assign the patient to onsite or offsite physical therapy. The research coordinator will assist with scheduling, track referrals, and record outcome data for patients referred offsite. If the PCP does not refer to physical therapy, patients will follow care recommendations provided by the PCP.
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For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml BMJ Open   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y   9 Outcomes, data collection, and storage Our primary outcome will be total costs and charges, which will be captured by the Duke University Health System Department of Finance using individual visits and corresponding billing codes for every subject enrolled. We will review each subject visit using medical record numbers. This will occur over the 3-month study period for each instance the subject presents with a pain complaint-including but not limited to office visits, ED visits, imaging appointments, etc.
Secondary outcomes include utilization, which will be captured through chart review of the subject's electronic medical record, monthly review of the electronic medical record for opioid prescriptions, physical therapy missed appointments, and review of the number of times patients visit the ED for MSK pain. Over a 3-month study period, we will analyze the ED visits for the type of pain and medications given. We are also measuring the type, date, and number of imaging referrals. Another secondary outcome will be patient and provider satisfaction, which will be evaluated via several tools: the Center for Epidemiological Studies Depression Scale (CESD; which measures depressive symptoms [17] ), the Keele Musculoskeletal Patient Reported Outcome (MSK-PROM) survey (which asks respondents to prioritize outcomes for different MSK conditions [18] ), the Patient Satisfaction Questionnaire Short Form (PSQ-18; which asks respondents how satisfied they are with their physical function and about their MSK function [19] ), and the PSQ-18 satisfaction survey (which also asks the patient how they feel about the health care they received and about their overall socioeconomic background). PCP satisfaction will be measured with the Maslach Burnout Inventory, a psychological assessment tool used to measure occupational burnout. Adverse events will be measured by participant report and by tracking provider and ED visits in the electronic health record. Adverse events will be defined by protocol as "any untoward physical or psychological occurrence by participating in research." Potential adverse events will be reported in accordance with Duke University Institutional Review Board requirements. These questionnaires will be given at both the initial appointment and at the 3-month follow-up. To gain feedback from our stakeholders (i.e., patients, providers, administrators, and staff), we will conduct focus groups and individual interviews, which will inform the refinement of a survey that will be more widely disseminated. All data collection and confidential storage will occur through Research Electronic Data Capture (REDCap) software, with only the research coordinator and principal investigator having access.
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Feasibility data
This study builds upon our previous model of physical therapists co-located within a primary care facility. [13] We previously examined 5370 patients seen by a PCP from April 2015 to April 2016, 27% (n=1445) of whom had a PCP encounter for a complaint of MSK pain. Of those, 32% were evaluated by a physical therapist (n=256 onsite and n=209 offsite) and were included in the study. Referral was based on provider choice, scheduling, and availability. We compared 12-month opioid prescriptions and ED visits for patients with a PCP appointment for an MSK complaint and referred for onsite physical therapy evaluation versus offsite evaluation. Outcomes were measured from the date of the PCP encounter, reflecting the decision for physical therapy involvement and site of care. Analyses of differences were conducted with chi-square tests of proportions. Outcomes were modeled by logistic regression in unadjusted, adjusted, and matched propensity models. Inverse probability weighting was used to match sociodemographic, clinical, and health service characteristics between patients receiving physical therapy onsite versus offsite. The study was approved by the Duke University Institutional Review Board.
Patients were 23-92 years of age (mean 55.8 years; SD 15.4). Altogether, 76% were women and 75% were African American. Primary diagnoses were back pain (n=427; 30%), knee pain (n=345; 24%), and upper extremity pain (n=332; 23%). Medicare and Medicaid were the primary payors (53% and 38%, respectively; Table 1 ). Opioid prescriptions were lower for patients seen by a physical therapist onsite versus offsite (64% vs. 76%, p<0.01; Table 2 ).
The majority (59%) of opioid prescriptions were for Medicare beneficiaries. There were 44% lower unadjusted odds of opioid prescription for patients seen by a physical therapist onsite versus offsite (OR 0.56, 95% CI 0.37-0.48). After adjusting for patient characteristics, the association was no longer significant (adjusted OR 0.72, 95% CI 0. 
Patient and Public Involvement
From our feasibility data, we found that MSK evaluation by PCP or physical therapist first directly addresses patients' priorities of having their chief health complaint addressed by a trained provider for MSK issues. This design for physical therapist first leads to the most efficient care pathway for targeted evaluation and treatment by an MSK-trained provider, and by reducing the number of provider handoffs, it also reduces the number of copayments required by the patient. Further, any medical needs raised by the patient during an appointment can be easily addressed in this colocated model. These concepts directly influenced the design of the current randomized clinical trial described in this protocol.
Some US health insurance providers require a referral to receive physical therapy services, which may necessitate an evaluation from a provider. Our second level of randomization addresses patient preferences regarding co-location directly. Patients who see a PCP first are randomized to on-site versus off-site physical therapy. Off-site could result in a delay to physical therapy services and may result in increased pain, cost and inconvenience to the patient compared with being able to access physical therapy services directly. The research question was developed to determine the impact of a physical therapist embedded within a primary care setting as the first line provider, which may improve efficiency of health care services, communication between providers, and access for patients.
Sample size estimates
Our sample size estimates are based on a superiority hypothesis positing that initial MSK evaluation by a physical therapist in a primary care setting will result in lower costs relative to initial MSK evaluation by a PCP. Sample size estimates for this study are based upon our prior feasibility cost data, which is consistent with previous literature from "early" versus "late" referral to physical therapy for low back pain. [6] Assuming a difference in costs between arms of the study of $2,800 with a standard deviation of $6,240, an alpha=0.05, and at 80% power we would need n=150 participants to complete the study. Given our primary aim is based upon costs related to care collected from our finance department, we anticipate few missing data. Our secondary outcomes are based upon 3-month telephone follow-up data collection. To account for a potential refusal rate of 20% to complete 3-month follow-ups, we would need to enroll participants. We selected a 20% attrition rate to account for the high no-show attendance rate at this clinic that could potentially impact study follow-up.
Quantitative analysis
We will calculate differences in total and MSK-specific costs and charges between the physical therapist evaluation group and the PCP group using standard analysis of variance or tests of medians, depending on the distribution of data (parametric vs. non-parametric). Secondary outcomes will be analyzed by analysis of variance for continuous outcomes or chi-square tests for categorical outcomes. We will also calculate changes in routinely collected disease-specific measures stored in the electronic medical record. Physical therapy missed appointments and patient and provider satisfaction will be reported as descriptive data. We will explore differences in these outcomes between onsite versus offsite physical therapy. Analyses will follow intent-to-treat assumptions. All analyses will be conducted in Stata V.15 (College Station, TX).
Qualitative analysis
Qualitative data from the focus groups and interviews will be transcribed and coded into themes. These codes will be based on the levels of influence on outcomes (patients, providers, models of care tested at the clinic, and local and national policies such as health insurance, access to providers, etc.) The intent is to understand barriers and facilitators, needs, and preferences at each level and between each level. We will use a constant comparative method to analyze the data and to identify relevant recurrent themes.
Strengths and limitations
There are several strengths of the IMPaC study, including randomization to decrease bias, implementation design, qualitative feedback from stakeholders, and an opportunity to create a health care redesign important for MSK care within the primary care setting. However, this design is not without limitations. Due to the nature of interventions by providers, we are unable to blind participants or providers to the arms of the study. Therefore, we cannot rule out the potential for information bias with outcome ascertainment. This is a single-site study and therefore there is a risk of contamination between groups that would greatly be reduced with a cluster design. Also, the workflow and procedures for conducting provider examinations may differ across sites, which may impact recruitment, enrollment, and exposure to physical therapy or primary care. This is also a single health care system, and there may be large variation in the way in which the health care process occurs between systems. Our single site is also unique in the demographic, race, and insurance distributions across patients. This site has a higher-than-average African American population, older age, and higher proportion of Medicare and Medicaid payor mix than other primary care / internal medicine clinics across our health care system. Therefore, results could differ in other clinics with respect to these factors.
ETHICS AND DISSEMINATION
Ethics approval was obtained by both the Duke University Institutional Review Board and the National Center for Advancing Translational Sciences. Verbal and written consent will be required from participants, including verbal consent for randomization to group assignment and scheduling with the provider and written consent for participation and collection of outcomes. This study was registered on ClinicalTrials.gov (#NCT03110211) and approved on August 22, 2017. Amendments to the protocol will be noted within any resulting publications. Results will be presented through institutional, local, and national venues via conference presentations and publications.
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Methods and analysis:
This single-site, randomized clinical trial will test the hypothesis that a PT within a primary care facility as the initial evaluating provider for patients with an MSK complaint will lower costs, improve utilization (i.e., reduced opioid prescriptions, imaging, physical therapy, emergency department visits, and missed appointments), and increase patient satisfaction within 90 days of the index visit compared with PCP evaluation in the same location.
Participants aged ≥18 years will be randomized with equal allocation and stratified by pain site (i.e., back, knee, upper extremity, and other). In the initial PT evaluation arm, patients will be assessed, treated, and then instructed to complete a home exercise program. The PCP cohort will undergo a usual PCP evaluation, and if a referral to physical therapy is made, patients will be randomized to onsite versus offsite physical therapy. Differences will be calculated and tested across the 2 arms.
Ethics and dissemination:
Approval was received from the Duke University Institutional Review Board (05/01/2017) and the National Institutes of Health, National Center for Advancing Translational Sciences (06/01/2017). Findings will be communicated via quarterly reports to funding bodies and disseminated through scientific publications.
Trial registration number: ClinicalTrials.gov #NCT03110211.
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Strengths and limitations of the study:
• Physical therapists will be integrated within a primary care setting to be the initial evaluating provider for patients with musculoskeletal complaints.
• Physical thearpy referral by the primary care physician is evaluated by a second level of randomization to onsite physical therapy at the primary care location versus usual care to an offsite location.
• Qualitative feedback is gathered from various stakeholders via focus groups and individual interviews.
• Blinding of the patients and providers was not possible due to the nature of the intervention which may affect participation and outcomes.
• This is a single-site study and workflows, payer distribution and patient demographics may be different from our single site and others within our healthcare system as well as across other healthcare systems. Recent studies have demonstrated that early referral to a physical therapist for low back pain can decrease health care costs by reducing imaging, specialist referrals, and opioid prescriptions. [4] [5] [6] Nevertheless, physical therapy referrals for MSK pain evaluation and management are disproportionately less than expected, [7] and the uptake of clinical guidelines has been slow. [8] [9] [10] To make matters worse, referral for physical therapy at an offsite location (which is standard practice) may negatively impact care continuity, provider communication, collaboration, and patient satisfaction. In contrast, coordinated care models (i.e., co-location and integration) have been shown to positively impact outcomes for prevalent conditions in primary care, but data on the effectiveness of these models for MSK conditions are lacking.
Study design
Participant eligibility and recruitment
All existing patients (n=3918), defined as establishing care within the past 3 years and having at least 1 visit in the last 12 months, at the Duke Outpatient Clinic will be mailed an announcement (opt-in/opt-out) letter about the study. Existing patients, all of whom should have received an announcement letter, will be recruited in 3 ways : 1) patients who contact the research coordinator for eligibility screening; 2) patients who contact the main scheduling center for an MSK complaint; and 3) patients who are on the daily schedule with an MSK complaint. All patients not meeting the definition of a current patient will be considered a new patient. Patients establishing care at the site for the first time will be recruited by either responding to an announcement letter or via referral by their new provider to the study research coordinator.
Enrollment and overview
Participants who call the scheduling center or contact the research coordinator about the study will be screened via telephone for eligibility and asked to verbally consent to participate. Following verbal consent by the research coordinator, participants will be randomized to an intervention arm by use of a computer-generated randomization table programmed into the study tracking database. Due to the nature of the intervention, both patients and interventionists will not be blinded to group assignment. Upon initial visit to the clinic, participants will provide written consent, demographic information, and health status. Patients assigned to the physical therapist group will receive an evaluation for their MSK complaint(s) by a licensed physical therapist onsite and will be provided with a treatment plan that will follow usual care currently implemented in clinical practice. Patients may return to the Duke Outpatient Clinic for follow-up treatments if the physical therapist deems it medically necessary or may be referred for physical therapy offsite. Patients assigned to the PCP group will receive an initial evaluation from a licensed primary care provider onsite that will follow usual care. The PCP may then refer the patient for physical therapy. If so, the patient will be randomly assigned to either the physical therapist onsite or referral to an offsite physical therapy clinic of the patient's choosing, with the assistance of the research coordinator. The purpose of this second randomization is to determine if outcomes differ based on whether participants receive physical therapy onsite at the primary care location or receive a referral to an offisite location of their choosing. If the PCP decides that physical therapy is not medically necessary, the patient will follow the PCP's usual plan of care and treatment recommendations. Following evaluation by either the physical therapist or PCP, the research coordinator will ask the patient to complete a short patient satisfaction survey about the initial visit. Participants will receive a gift worth $20 for completing the baseline requirements. After approximately 3 months, the research coordinator will contact all enrolled patients by phone to collect health statuses and satisfaction measures. Also, at 3 months, outcomes related to total and MSK costs/charges will be collected via the Duke University Health System Department of Finance, opioid prescriptions and ED visits will be collected via electronic health records and administrative data, and offsite referrals to physical therapy will be collected via administrative data from the Department of Physical and Occupational Therapy. Investigators will also collect, via electronic health record, usual care measures of functional status. The study will end following the 3-month follow-up phone call and collection of outcomes and data.
Inclusion/exclusion criteria
Potential participants will be considered eligible if they have an MSK pain complaint and are within the target sample population. Based on clinical experience at the research site, any adult (≥18 years) reporting an MSK pain complaint will be included. Patients without legal capacity (mental or psychological stability) to provide informed consent will be excluded. Patients will be withdrawn from the study if the physical therapist believes the patient may have an underlying medical condition that makes the patient inappropriate for physical therapy care. [15, 16] In this case, the participant will be referred to a clinic PCP for further evaluation.
Study interventions
Physical Therapist Evaluation: This intervention builds upon our current clinical model of a physical therapist colocated within the Duke Outpatient Clinic. The physical therapist has an assigned treatment room, is available for scheduled follow-up appointments, attends staff meetings and events, and is considered a provider within the Duke Outpatient Clinic system. Co-location is fully supported by the administration of the clinic and the Department of Physical Therapy and Occupational Therapy. The utilization of physical therapy services is considered usual care;
however, the timing of services is unique given the co-location. This allows for prompt access to not only a physical therapy evaluation (billing for services occurs), but for consultation with a PCP (a contact note for consultation is included in the patient's medical records). For IMPaC, investigators will utilize this co-located physical therapist as a front-line provider for patients seeking care for MSK complaints at the clinic. The physical therapy evaluation will be usual care and will not be modified in any way for the purposes of the study. If, at any time during evaluation, the physical therapist determines that the patient would benefit from an additional PCP assessment, the patient will be scheduled for one. These referrals from the physical therapist to the PCP can occur within the same day, which adds considerable efficiency.
PCP Evaluation: In this cohort, patients will undergo initial assessment by the PCP, which is considered usual care. If the PCP deems that the patient should be referred for physical therapy for medically necessary treatment, the research coordinator will randomly assign the patient to onsite or offsite physical therapy. The research coordinator will assist with scheduling, track referrals, and record outcome data for patients referred offsite. If the PCP does not refer to physical therapy, patients will follow care recommendations provided by the PCP. Outcomes, data collection, and storage
Our primary outcome will be total costs and charges, which will be captured by the Duke University Health System Department of Finance using individual visits and corresponding billing codes for every participant enrolled. We will review each participant visit using medical record numbers. This will occur over the 3-month study period for each instance the participant presents with a pain complaint-including but not limited to office visits, ED visits, imaging appointments, etc.
Secondary outcomes include utilization, which will be captured through chart review of the participant's electronic medical record, monthly review of the electronic medical record for opioid prescriptions, physical therapy missed appointments, and review of the number of times patients visit the ED for MSK pain. Over a 3-month study period, we will analyze the ED visits for the type of pain and medications given. We are also measuring the type, date, and number of imaging referrals. Another secondary outcome will be patient and provider satisfaction, which will be satisfaction survey (which also asks the patient how they feel about the health care they received and about their overall socioeconomic background). PCP satisfaction will be measured with the Maslach Burnout Inventory, a psychological assessment tool used to measure occupational burnout. Adverse events will be measured by participant report and by tracking provider and ED visits in the electronic health record. Adverse events will be defined by protocol as "any untoward physical or psychological occurrence by participating in research." Potential adverse events will be reported in accordance with Duke University Institutional Review Board requirements.
To gain feedback from our stakeholders (i.e., patients, providers, administrators, and staff), we will conduct focus groups, individual interviews and satisfaction feedback via telephone. Providers and administrators will be selected to participate in the focus groups and individual interviews based on availability and experience with the model of care described in the study. The focus groups and individual interviews will be facilitated by the study team using a pre-determined set of discussion questions. Sessions will be tape recorded and transcribed for further analysis. Focus groups, interviews and telephone feedback will be conducted according the Duke Univestiy Institutional Review Board requirements. Participants in the study will also be asked, via telephone, during 3-month follow-up about their experiences with the model of care and any feedback from this experience that can be used to refine the current model.
All data collection and confidential storage will occur through Research Electronic Data Capture (REDCap) software, with only the research coordinator and principal investigator having access.
Patient and Public Involvement
Neither patients or the public were directly involved in the study design or conduct of the study. No plans were established a-priori for sharing the results of the study with participants.
Sample size estimates
Our sample size estimates are based on a superiority hypothesis positing that initial MSK evaluation by a physical therapist in a primary care setting will result in lower costs relative to initial MSK evaluation by a PCP. Sample size estimates for this study are based upon our prior feasibility cost data, which is consistent with previous literature from "early" versus "late" referral to physical therapy for low back pain. [6] Assuming a difference in costs between arms of the study of $2,800 with a standard deviation of $6,240, an alpha=0.05, and at 80% power we would need a total of n=150 participants, with equal allocation to one of the arms, to complete the study. Given our primary aim is based upon costs related to care collected from our finance department, we anticipate few missing data. Our secondary outcomes are based upon 3-month telephone follow-up data collection. To account for a potential refusal rate of 20% to complete 3-month follow-ups, we would need to enroll n=195 participants. We selected a 20% attrition rate to account for the high no-show attendance rate at this clinic that could potentially impact study follow-up.
Quantitative analysis
Qualitative analysis
Strengths and limitations
There are several strengths of the IMPaC study, including randomization to decrease bias, implementation design, qualitative feedback from stakeholders, and an opportunity to create a health care redesign important for MSK care within the primary care setting. However, this design is not without limitations. Due to the nature of interventions by providers, we are unable to blind participants or providers to the arms of the study. Therefore, we cannot rule out the potential for information bias with outcome ascertainment. This is a single-site study and therefore there is a risk of contamination between groups that would greatly be reduced with a cluster design. Also, the workflow and procedures for conducting provider examinations may differ across sites, which may impact recruitment, enrollment, and exposure to physical therapy or primary care. In addition, a participant in the PCP group that is referred to physical therapy and randomized onsite or offsite may not have their location preference met which may affect multiple outcomes. This is also a single health care system, and there may be large variation in the way in which the health care process occurs between systems. Our single site is also unique in the demographic, race, and insurance payer distributions across patients. This site has a higher-than-average African American population, older age, and higher proportion of Medicare and Medicaid payor mix than other primary care / internal medicine clinics across our health care system. Therefore, results could differ in other clinics with respect to these factors. Lastly, the source population from which we are recruiting for this study includes both established patients and patients establishing care with an MSK complaint within this primary care facility. Therefore, these results may not be representative of only new patients for care of a new episode of MSK pain complaint.
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